Guardian Pharmacy Services (GRDN) Liabilities and Shareholders Equity (2023 - 2026)

Guardian Pharmacy Services (GRDN) has 4 years of Liabilities and Shareholders Equity data on file, last reported at $426.9 million in Q1 2026.

• Quarterly Liabilities and Shareholders Equity rose 27.83% year-over-year to $426.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 billion (up 58.15% YoY) and the FY2025 annual result came in at $412.7 million, up 28.63% from the prior year.
• Liabilities and Shareholders Equity climbed to $426.9 million in Q1 2026 per GRDN's latest filing, from $412.7 million in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $426.9 million in Q1 2026, with the low at $271.2 million in Q4 2023.
• Average Liabilities and Shareholders Equity over 4 years is $357.5 million, with a median of $352.2 million recorded in 2024.
• The widest YoY moves for Liabilities and Shareholders Equity: up 28.63% in 2025, down 12.07% in 2025.
• Guardian Pharmacy Services' Liabilities and Shareholders Equity stood at $271.2 million in 2023, then gained by 18.31% to $320.8 million in 2024, then grew by 28.63% to $412.7 million in 2025, then gained by 3.46% to $426.9 million in 2026.
• Business Quant data shows GRDN's Liabilities and Shareholders Equity at $426.9 million in Q1 2026, $412.7 million in Q4 2025, and $390.0 million in Q3 2025.